SEOUL -- South Korean drugmaker Samsung Biologics will begin producing the Moderna coronavirus vaccine following an agreement struck during President Moon Jae-in's trip to Washington last week.
COVID vaccines
Samsung Biologics to make Moderna vaccine in Biden summit takeaway
Incheon production deal comes after Moon government faced criticism on supply front
